Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Research findings could lead to improved treatments for brain and spinal cord injuries

Hot on the heels of discovering a protective form of immune response to spinal cord injury, researchers at the University of Virginia School of Medicine have pinpointed the biological trigger for that response - a vital step toward being able to harness the body's defenses to improve treatment for spine injuries, brain trauma, Alzheimer's disease and other neurodegenerative conditions.

6 Feb 2015

Meditation appears to help preserve the brain's gray matter

Since 1970, life expectancy around the world has risen dramatically, with people living more than 10 years longer. That's the good news.

6 Feb 2015

Alzheimer's brains commonly have many neurons with more DNA and genomic copies of APP gene

Scientists at The Scripps Research Institute have found diverse genomic changes in single neurons from the brains of Alzheimer's patients, pointing to an unexpected factor that may underpin the most common form of the disease.

5 Feb 2015

Resveratrol found in red grapes, peanuts may help prevent age-related decline in memory

A compound found in common foods such as red grapes and peanuts may help prevent age-related decline in memory, according to new research published by a faculty member in the Texas A&M Health Science Center College of Medicine.

5 Feb 2015

Hockey legend diagnosed with suspected Lewy body dementia

The sad news of hockey legend Stan Mikita's illness has brought unexpected visibility to a disease unfamiliar to many people.

4 Feb 2015

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

Sangamo BioSciences, Inc. announced today that an Investigational New Drug (IND) application for the company's SB-BCLmR-HSPC genome editing approach, which is designed to provide a one-time lasting therapy for beta-thalassemia, has been accepted by the U.S. Food and Drug Administration and is now active.

4 Feb 2015

SuperAgers have distinctly different looking brains

SuperAgers, aged 80 and above, have distinctly different looking brains than those of normal older people, according to new Northwestern Medicine research that is beginning to reveal why the memories of these cognitively elite elders don't suffer the usual ravages of time.

4 Feb 2015

Cooking foods at high temperatures increases Alzheimer's risk

Our new paper published in the Journal of Alzheimer's Disease provides evidence that cooking foods at high temperatures increases the risk of Alzheimer's disease. This study looked at the content of advanced glycation end products (AGEs) in national diets and clinical studies comparing and compared total AGEs to Alzheimer's disease rates.

4 Feb 2015

Free dementia workshops to be held at Houston's Alzheimer's Association

Since December 2003, Marsene Boldt, RN, has been providing care services for Houston area residents with her At Your Side Home Care location at 16868 Royal Crest Dr.

4 Feb 2015

Congressman Fattah meets with Amarantus regarding research efforts for degenerative brain diseases

Congressman Chaka Fattah (D-PA), architect of the Fattah Neuroscience Initiative, met last week with Amarantus, a biotechnology company on their recent efforts to develop treatment and diagnostics for degenerative brain diseases, including Alzheimer's.

4 Feb 2015

Study may offer insight into pathology of autism, Alzheimer's disease

For parents of children struggling with autism, the dearth of information is heartbreaking. Medical professionals are hard put to answer the primary questions: Who is autistic? What causes autism? What treatments are available? The situation is similar for Alzheimer's patients and relatives, who are helpless before the aggressive disease devouring a sufferer's identity.

4 Feb 2015

Mathematical models of cancer behavior offer new insights on tumor growth

Hassan Fathallah-Shaykh, M.D., Ph.D., believes that math can transform medicine, and he has the numbers to prove it.

2 Feb 2015

People's perceptions of cost of drug may affect how much they benefit from it

People's perceptions of the cost of a drug may affect how much they benefit from the drug, even when they are receiving only a placebo, according to a new study of people with Parkinson's disease published in the January 28, 2015 online issue of Neurology®, the medical journal of the American Academy of Neurology.

2 Feb 2015

JetFuel Technologies, Valtronic team up to reduce brain injuries

Valtronic develops partnerships built on the creation of innovative ideas, technology, and positive outcomes for all.

31 Jan 2015

Scientists reveal mechanism underlying cellular degeneration of upper motor neurons

For the first time, scientists have revealed a mechanism underlying the cellular degeneration of upper motor neurons, a small group of neurons in the brain recently shown to play a major role in ALS pathology.

31 Jan 2015

BTH to develop new technologies to improve quality of life for elderly people with mild dementia

Blekinge Institute of Technology in Sweden will receive 10 million SEK to develop new technologies that will increase the quality of life for elderly people with mild dementia. The technology, IT support via e-readers, will also facilitate for the relatives.

30 Jan 2015

Gradual smoking cessation may be key for quitting

Smoking is harmful in almost every respect. Cancer, stroke, and other cardiovascular diseases are just a small part of a well-documented portfolio of serious consequences of smoking.

29 Jan 2015

People who carry longevity gene variant have larger brain region

People who carry a variant of a gene that is associated with longevity also have larger volumes in a front part of the brain involved in planning and decision-making, according to researchers at UC San Francisco.

29 Jan 2015

ADDF awards grant to support initiation of AGB101 Phase 3 trial for aMCI treatment

The Alzheimer's Drug Discovery Foundation announced today a $900,000 grant to AgeneBio, a pharmaceutical company developing innovative therapies for neurologic and psychiatric diseases. The grant will support the initiation of an FDA-registered Phase 3 clinical trial of AGB101, a new therapeutic treatment for amnestic mild cognitive impairment (aMCI).

28 Jan 2015

Reducing A2A adenosine receptor levels prevents memory impairments in Alzheimer's mouse model

A study by scientists from the Gladstone Institutes shows that decreasing the number of A2A adenosine receptors in a particular type of brain cells called astrocytes improved memory in healthy mice. What's more, reducing receptor levels also prevented memory impairments in a mouse model of Alzheimer's disease.

28 Jan 2015

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Research findings could lead to improved treatments for brain and spinal cord injuries

Meditation appears to help preserve the brain's gray matter

Alzheimer's brains commonly have many neurons with more DNA and genomic copies of APP gene

Resveratrol found in red grapes, peanuts may help prevent age-related decline in memory

Hockey legend diagnosed with suspected Lewy body dementia

FDA accepts Sangamo BioSciences' IND for SB-BCLmR-HSPC genome editing approach

SuperAgers have distinctly different looking brains

Cooking foods at high temperatures increases Alzheimer's risk

Free dementia workshops to be held at Houston's Alzheimer's Association

Congressman Fattah meets with Amarantus regarding research efforts for degenerative brain diseases

Study may offer insight into pathology of autism, Alzheimer's disease

Mathematical models of cancer behavior offer new insights on tumor growth

People's perceptions of cost of drug may affect how much they benefit from it

JetFuel Technologies, Valtronic team up to reduce brain injuries

Scientists reveal mechanism underlying cellular degeneration of upper motor neurons

BTH to develop new technologies to improve quality of life for elderly people with mild dementia

Gradual smoking cessation may be key for quitting

People who carry longevity gene variant have larger brain region

ADDF awards grant to support initiation of AGB101 Phase 3 trial for aMCI treatment

Reducing A2A adenosine receptor levels prevents memory impairments in Alzheimer's mouse model

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Newsletters you may be interested in